Patents for A61P 39 - General protective or antinoxious agents (19,019)
03/2010
03/03/2010EP1937639B1 Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)
03/03/2010EP1496920B1 Pharmaceutical composition containing an extract from barleria prionitis linn and its process of preparation
03/03/2010CN101659639A Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
03/02/2010US7671211 Substrates for thioredoxin reductase
02/2010
02/25/2010US20100048698 Macrocyclic diterpenes for treating conditions associated with protein kinase c
02/24/2010EP1501774B9 Polyunsaturated linear aldehydes and their derivatives with anti-radical activity
02/23/2010USRE41151 Comprising a modified NSAID, wherein the NSAID is covalently attached either directly or through a linker molecule to a sulfur-containing functional group containing an optionally substituted hydrocarbyl moiety; nonsteroidal anti-inflammatory drugs; side-effect reduction
02/23/2010US7666867 Heteroindanes: a new class of potent cannabimimetic ligands
02/18/2010WO2009127982A3 Novel synthesis and applications of amino carboxylates
02/18/2010US20100041723 Thiazole Compound (as PPAR delta) Ligand and Pharmaceutical, Cosmetic and Health Food Comprised Thereof
02/18/2010US20100040695 Methods for providing nutritional products for customized energy intake
02/18/2010US20100040604 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
02/17/2010EP1606021B1 Manganese based organometallic complexes, pharmaceutical compositions and dietetic products
02/16/2010CA2402436C Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
02/16/2010CA2309154C Substituted porphyrins
02/11/2010WO2010017332A2 Radioprotectants targeting thrombospondin-1 and cd47
02/11/2010WO2010015827A2 Phosphate binding materials and their uses
02/11/2010US20100035869 Targeted nitroxide agents
02/11/2010CA2732226A1 Phosphate binding materials and their uses
02/11/2010CA2732102A1 Radioprotectants targeting thrombospondin-1 and cd47
02/10/2010CN100588647C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
02/09/2010US7658939 Inert core, first layer comprising naltrexone, nalmefene or salts; and second hydrophobic layer; pain treatment
02/09/2010CA2439593C Heterocyclic compounds for aging-related and diabetic vascular complications
02/09/2010CA2431079C Method and composition for the treatment of diabetic neuropathy
02/04/2010WO2010014873A2 Method of preparing a muscadine pomace extract
02/04/2010WO2010014870A2 Muscadine compositions with improved anti-oxidant activity
02/04/2010WO2010013987A2 Extraction method for increasing liquiritigenin content in glycyrrhizae radix et rhizoma or glycyrrhizae radix extract
02/04/2010WO2010013551A1 Preparation for oral administration comprising water-extracted chondroitin sulfate and quercetin glycoside
02/04/2010WO2009019260A3 Use of tlr-2 antagonists for treatment of reperfusion injury and tissue damage
02/04/2010US20100029744 Methods for Alzheimer's Disease Treatment and Cognitive Enhancement
02/04/2010CA2732426A1 Method of preparing a muscadine pomace extract
02/04/2010CA2732306A1 Muscadine compositions with improved anti-oxidant activity
02/03/2010EP1351679B1 Method and composition for the treatment of diabetic neuropathy
02/02/2010US7655694 Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury
02/02/2010CA2494583C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
01/2010
01/28/2010WO2010011533A2 Compositions and methods for increasing serum antioxidant concentrations
01/28/2010US20100022643 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
01/28/2010US20100022557 Radioprotector compounds and related methods
01/28/2010US20100022520 Malonyl-coa acetyltransferase inhibitors against antibiotic resistant bactertia
01/28/2010US20100021493 Extracts of aphanizomenon flos aquae and nutritional, cosmetic and pharmaceutical compositons containing the same
01/28/2010CA2731463A1 Compositions and methods for increasing serum antioxidant concentrations
01/27/2010CN100584819C Substituted 4-aminocyclohexanol derivatives
01/27/2010CN100584339C Novel use of inorganic carbonate
01/27/2010CN100584328C Use of chlorogenic acid in preparing antihypoxic medicament or foods
01/26/2010US7652155 Diamine derivative, production process therefor and antioxidant
01/26/2010US7651692 Skin disorders; cosmetics; aging resistance
01/26/2010CA2456606C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
01/26/2010CA2426852C Formulation containing phosphate derivatives of electron transfer agents
01/26/2010CA2213567C Use of ketamine for facilitating detoxification and treatment of smoking addiction, and device therefor
01/21/2010WO2010006809A2 Medical use of the radical scavenger and antioxidant alpha-1-microglobulin
01/21/2010WO2010006634A1 Prevention and treatment of radiation injury
01/21/2010US20100016557 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
01/21/2010US20100016216 Adiponectin and uses thereof
01/21/2010US20100015115 Compound preparation for quickly reducing oxidative stress and preparation of the same
01/21/2010CA2730531A1 Medical use of the radical scavenger and antioxidant alpha-1-microglobulin
01/20/2010EP2145873A1 New compounds with activity that protects against the action of toxins and viruses in intracellular action mode
01/20/2010EP2145623A1 Pharmaceutical and cosmetic compositions for accelerated healing of wounds and other surface damages
01/20/2010EP1506214B1 6-11 bicyclic ketolide derivatives
01/20/2010CN201384712Y Sodium ferulate enteric-coated tablet
01/20/2010CN100582234C Use of krev alcohol in preparing antioxidation agent
01/20/2010CN100582101C Antitumoral agent
01/20/2010CN100581562C Preparation method for separating and purifying extractive from lotus leaves, and usage
01/20/2010CN100581556C Chinese traditional extraction and the function containing dammarane type four-ring triterpene sapogenin
01/19/2010US7648710 Formulation containing phosphate derivatives of electron transfer agents
01/19/2010CA2466869C Methods and compositions for ameliorating the undesirable effects of chemotherapy
01/14/2010WO2010005012A1 Apolactoferrin-containing composition
01/14/2010WO2010003178A1 A synthetic vaccine component
01/14/2010US20100008895 used in vaccines against A. salmonicida infections such as fish disease furunculosis; ADP-ribosylating toxins
01/14/2010CA2730377A1 Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
01/14/2010CA2730258A1 Mineral amino acid polysaccharide complex
01/13/2010EP2143434A1 Composition for promoting ketone compound formation
01/13/2010EP2143429A1 Use of cilastatin to reduce the nephrotoxicity of different compounds
01/13/2010EP2142664A1 Estimation and biological consequences of oxidative metabolism
01/13/2010EP2142199A2 A process to activate extracts derived from living organisms using long wave uv irradiation and compositions comprising said activated extract
01/13/2010CN100579974C Podocarpus extract and its preparation method
01/13/2010CN100579536C Preparation method for graininess medicine containing hirsutella hepia - cordyceps fungus powder
01/12/2010CA2483678C 6-11 bicyclic ketolide derivatives
01/07/2010WO2010003092A1 Methods and compositions for reducing inflammation and treating inflammatory disorders
01/07/2010WO2010000964A1 Microbiological method for synthesizing cinnamoyl amide derivatives of amino acids
01/07/2010WO2010000013A1 A sulfated polysaccharide compound and the preparation and use thereof
01/07/2010WO2009135311A8 Echinoderm-derived extracts, methods of preparation and uses thereof
01/07/2010US20100003263 Monoclonal antibodies to anthrax protective antigen
01/07/2010DE202009013065U1 Granatapfelpolyphenole, Vitamin D und Spurenelemente enthaltende Zusammensetzung Pomegranate polyphenols, vitamin D and trace elements containing composition
01/06/2010EP2140147A2 Clip-on, clip off mounting device as for a portable light
01/06/2010EP2139465A1 Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level
01/06/2010CN100577189C Fat-benefiting health care composition capsule and its preparing method
01/05/2010US7641922 Preparation and application of transhintotalphenolic acid
01/05/2010CA2429162C Methods and compositions for enhancing cellular function through protection of tissue components
12/2009
12/31/2009US20090325982 Phosphodiesterase 4 inhibitors
12/31/2009US20090324758 Plant extract mixtures and their uses
12/30/2009WO2009157886A1 Antitumoral, antioxidant and immunomodulatory composite agent
12/30/2009WO2009157575A1 Skin preparation for external use, whitening agent, anti-aging agent, and antioxidant
12/30/2009WO2009130604A3 Solid state forms of deferasirox salts and process for the preparation thereof
12/30/2009WO2009023742A3 Spore displaying antigens
12/30/2009EP2138170A2 Prevention and Treatment of Oxidative Stress Disorders by compounds which elevate intracellular levels of glutathione or Phase II Detoxification Enzymes
12/30/2009EP2137170A1 Desferrithiocin polyether analogues
12/30/2009CN201372259Y Manufacturing system extracting chitosan of antibiotic peptide substance from maggots
12/30/2009CN100575363C Human source anti-A botulinum neurotoxin genetic engineering antibody and preparation method and use thereof
12/30/2009CN100575350C Macrocyclic glyceride with oxidization resistant activity and its preparation method and use
12/30/2009CN100574630C Low-salinity autumn and winter cultivation ecological bait for litopenaeus vannamei and its preparation method
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 191